Literature DB >> 10390244

Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance.

L J van Doorn1, Y J Debets-Ossenkopp, A Marais, R Sanna, F Mégraud, J G Kusters, W G Quint.   

Abstract

A PCR-based reverse hybridization system (research prototype kit INNO-LiPA for H. pylori resistance) was developed and evaluated for simultaneous detection of 23S ribosomal DNA point mutations, associated with macrolide resistance in Helicobacter pylori. Fifty-seven H. pylori strains (51 natural, 6 laboratory-derived artificial, 52 resistant, and 5 susceptible strains) were tested by PCR-LiPA (detecting mutations A2115-->G, G2141-->A, A2142-->G, A2142-->C, A2143-->G, A2143-->C, and A2143-->T), DNA sequencing, restriction fragment length polymorphism, and/or hybridization to oligonucleotide probes. Results were highly concordant, but PCR-LiPA appears to be more sensitive for the simultaneous detection of multiple mutants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390244      PMCID: PMC89365     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Ecology of Helicobacter pylori in the human stomach.

Authors:  M J Blaser
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.

Authors:  K Hultén; A Gibreel; O Sköld; L Engstrand
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 3.  Resistance of Helicobacter pylori to antibiotics.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

Review 4.  The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?

Authors:  W A de Boer; G N Tytgat
Journal:  Scand J Gastroenterol       Date:  1995-05       Impact factor: 2.423

5.  Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; M Sparrius; J G Kusters; J J Kolkman; C M Vandenbroucke-Grauls
Journal:  FEMS Microbiol Lett       Date:  1996-08-15       Impact factor: 2.742

6.  Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.

Authors:  A A van Zwet; W A de Boer; P M Schneeberger; J Weel; A R Jansz; J C Thijs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

Review 7.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

8.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.

Authors:  Y Glupczynski; M Labbé; W Hansen; F Crokaert; E Yourassowsky
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase.

Authors:  M Pina; A Occhialini; L Monteiro; H P Doermann; F Mégraud
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more
  24 in total

Review 1.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin.

Authors:  Armelle Ménard; Adriana Santos; Francis Mégraud; Mónica Oleastro
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 4.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

5.  Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays.

Authors:  K A Ryan; L J van Doorn; A P Moran; M Glennon; T Smith; M Maher
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Detection of azithromycin resistance in Treponema pallidum by real-time PCR.

Authors:  Mark W Pandori; Charmie Gordones; Lina Castro; Joseph Engelman; Mark Siedner; Sheila Lukehart; Jeffrey Klausner
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

7.  Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study.

Authors:  L J van Doorn; Y Glupczynski; J G Kusters; F Mégraud; P Midolo; N Maggi-Solcà; D M Queiroz; N Nouhan; E Stet; W G Quint
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

8.  Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal.

Authors:  Vincenzo De Francesco; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Rosa Rosania; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

Review 9.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens.

Authors:  Claudia Schabereiter-Gurtner; Alexander M Hirschl; Brigitte Dragosics; Peter Hufnagl; Sonja Puz; Zsuzsanna Kovách; Manfred Rotter; Athanasios Makristathis
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.